News
MedInvest is hosting a MedTech, AI & Digital Health Conference December 10-11, 2025 in New York City. NIH National Cancer Institute’s Michael Salgaller will be speaking. He will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions
A novel anti-cancer therapy to target the Proviral Integration of the Moloney murine leukemia virus (PIM) kinases is available for licensing and co-development. PIM kinases are overexpressed in many solid cancers, which is predictive of poor survival in multiple cancer types. NIH inventors have
Are you interested in learning more about technology transfer? The Technology Transfer Society – Washington D.C. chapter is running an Introduction to Technology Transfer and Commercialization course in conjunction with Montgomery College. This course is intended to provide students with an overview
The American Chemical Society (ACS) has awarded Kenneth Jacobson the E.B. Hershberg Award for Important Discoveries in Medicinally Active Substances. Jacobson is a Senior Investigator at the National Institute for Diabetes and Digestive and Kidney Diseases. Jacobson was selected for this award for